Month: October 2019
-
Merck Gaining Gut Microbe Technology for Vaccines
Drug maker Merck & Co. is partnering with a developer of treatments for disease derived from microbes in the gut, for discovery of up to three vaccines.
-
Heartbeat Biometric Security Device Being Developed
A national lab and security company are developing a device using a person’s unique heart beat pattern as a signature for controlling access.
-
Peanut Allergy Patch Under FDA Review
A device to build a tolerance of peanuts in children with a peanut allergy, worn like a patch on the skin, is under review by the Food and Drug Administration.
-
Dementia Drug Candidate in Preclinical Tests
A study is underway of a new treatment approach for dementia that targets inflammation and microscopic bleeding in the brain that can accompany Alzheimer’s disease.
-
Infographic – Private R&D Outpacing Defense Contractors
Our infographic this weekend offers a stark illustration of how private companies have surpassed defense contractors in R&D spending.
-
Women-Founded Start-Ups Raise More Capital Than Male-Only
Start-up enterprises founded or led by at least one woman on the team raise more capital than comparable start-ups founded by men only.
-
App Detects Early Eye Disease Symptoms from Photos
In tests with thousands of children’s photographs, a smartphone app shows it can detect early symptoms of serious eye diseases, including cancer.
-
Small Biz Grant Funds Prenatal Genetic Test
A small business set-aside grant is funding early development of a non-invasive prenatal test that simplifies detection of genetic abnormalities in a fetus.
-
Leg Prosthetic System Restores Sensory Feedback
Results from a small clinical trial shows a system for leg prosthetic devices restores tactile sensory feedback to improve mobility and reduce falling.
-
Nanotech Crispr Delivery in Development
Researchers in biochemistry and structural biology are designing a technique using nanoscale particles to safely deliver edited genes as a cancer treatment.